Eli Lilly's profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.
MENLO PARK, Calif., January 10 ... fund to fuel broader innovation in human health, in partnership with Eli Lilly and Company ("Lilly"). The Biotech Ecosystem Venture Fund ("Fund") seeks to ...
FLORHAM PARK, N.J. - BeyondSpring Inc . (NASDAQ: NASDAQ:BYSI), a biopharmaceutical company specializing in the development of ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Andreessen ... to fuel broader innovation in human health, in partnership with Eli Lilly and Company (“Lilly”). The Biotech Ecosystem Venture Fund ...
The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...
The campus houses over 50 multinational companies, including IBM, Target, Philips, Fidelity, and Nokia, and supports a daily ...
Eli Lilly has said it is seeking permission to build ... and detail a facility located at Raheen Business Park near Shannon Airport, according to an Irish Examiner report. The plant will be ...
Indiana's workforce is feeling pressure to return to the office, but a good portion of employees still like hybrid work. Is ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.
Today, we're tracking presentations from GSK, Novartis, Sanofi, Eli Lilly and other companies ... this is not a walk in the park, because there is a clear understanding by physicians that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results